Sources say Syngenta’s planned US$5 bln Hong Kong IPO could be delayed as the
company waits for an agricultural-sector recovery; advisers consider a 2027
listing more likely. Syngenta on July 16 declined to comment on market rumours
and said it will return to the capital markets when timing is right.